The Singapore Gastric Cancer Consortium (SGCC) is a translational research group comprising clinicians and scientists working in gastric cancer research. With the support of gastric cancer research grants, the group aims to solve important clinical questions to improve the care of gastric cancer patients.

HBV Cure is developed by the Singapore Hepatitis B Consortium who have been working collaboratively to focus on the eradication of Chronic Hepatitis B. Supported by hepatitis B research grants, the consortium adopts a comprehensive approach via 3 integrated themes: ‘Biology of Chronic Hepatitis B’, ‘Intrahepatic Hepatitis B’ and ‘Target Validation, Assay Development and Drug Screening’.

Growing Up in Singapore Towards healthy Outcomes (GUSTO) and Singapore PREconception Study of long-Term maternal and child Outcomes (S-PRESTO) are Singapore’s largest and most comprehensive birth cohort studies. Collectively, these studies will give us more insight and understanding into the prevention and management of important diseases in Singapore and improve the nation’s health.

Our Research Group, highly focused on VCI, involves multiple institutions and investigators from across Singapore, led by well-established and productive PIs, seeks to: Theme 1: undertake a multiple lifestyle interventional study to retard VCI-associated disease progression and to evaluate selected biomarkers for their predictive and surrogate outcome potential. Theme 2: assess longitudinal changes in brain structure, function and pathology using (MRI, PET, retinal) neuroimaging, as well as novel blood and genetic markers to determine their diagnostic and prognostic value as biomarkers. Theme 3: to link Themes 1 and 2 with health services research (HSR) on healthcare costs associated with VCI to facilitate clinical and policy decision making. Hence, we shall utilise basic, translational, clinical and implementation science approaches to improve the understanding of basic mechanisms underlying age-related VCI which will improve disease diagnosis, reduce incidence and progression through the development of new therapies and hence enhance quality of life.

Project RESET is a Singapore National Medical Research Council Large Collaborative Grant funded program that brings together a nationwide community of cardiovascular, metabolic, and digital health researchers, as well as clinicians across primary and tertiary care to study the immune, lipid and metabolic drivers of early cardiovascular disease. RESET incorporates a nested randomised controlled trials (RCT) to test the use of a combined digital wearable and AI-human symbiotic lifestyle intervention to halt or reverse the progression of early disease.

BISI aims to improve health and well-being through the use of behavioural and implementation science. BISI complements existing teaching and research at NUS Medicine, bringing a new focus on factors that influence health and healthcare.

CBmE is one of the largest academic research centres for bioethics in Asia. Our research areas are in clinical, health systems & public health ethics, ethics & regulation of emergent science & biomedical technologies, & research ethics & regulation.

Established by NUS Medicine and Lien Foundation, with core partners CEI and A*STAR’s SICS, CHILD is made up of experts in the field of translational research, child development, and implementation science to help give children the best start to life.

The Global Centre for Asian Women’s Health is established as a unit within the Dean’s Office, at the NUS Yong Loo Lin School of Medicine.  This centre aims to build a global research platform for transdisciplinary endeavors to address major health concerns over a woman’s lifespan.

The Bia-Echo Asia Centre for Reproductive Longevity and Equality (ACRLE), established under the NUS Yong Loo Lin School of Medicine (NUS Medicine), was made possible through a gift from the Bia-Echo Foundation, founded by lawyer and entrepreneur, Nicole Shanahan.

At the forefront of the net zero transition in healthcare, the Centre for Sustainable Medicine is delivering real-world change by training future healthcare leaders and equipping clinicians, industry, and health policymakers with the tools and evidence needed to respond at pace to climate change.

The Centre for Sleep and Cognition (CSC) comprises five multidisciplinary labs at the forefront of sleep, aging, health and cognitive neuroscience research. We use cutting-edge facilities integrating approaches such as EEG, fMRI and machine learning.

The Centre for Translational Magnetic Resonance Research (TMR) has dedicated MRI scanners for basic and translational research. TMR houses experts in various imaging modalities and collaborates with multiple academic institutions and industry.

CNRC aims to develop an integrated program that understands how food may be used to prevent and manage chronic disease and promote healthy aging. The centre’s mission is to use evidence-based science to make “Food the New Medicine”.

Clinical Imaging Research Centre (CIRC), offers state-of-the-art facilities for Magnetic Resonance (MR) Imaging and Positron Emission Tomography (PET) applied to clinical research, and is the only GMP-certified imaging facility in Singapore.

The Memory, Ageing, and Cognition Centre (MACC) was established in 2010. The MACC aims to investigate and provide novel insights into the risk factors and biomarkers for cognitive decline and dementia that may lead to potential therapeutic approaches.

The Heat Resilience & Performance Centre is a first-of-its-kind research centre focused on creating holistic and forward-looking solutions that boost human resilience to rising ambient heat.

The Centre for Innovation and Precision Eye Health seeks to address clinically unmet needs in ophthalmology. We aim to transform community eye care for the public, and to deliver world-class precision eye care for our patients.

The NUS-Agilent Hub provides research space to facilitate multidisciplinary collaborations among scientists, clinicians and industry partners to translate clinically relevant mass spectrometry-based tests into clinical applications.

The WIL@NUS research lab was jointly established with Wilmar International Limited with a focus on the clinical evaluation of functional food ingredients and food products and the bio-production of industrial enzymes and biochemicals.

NUS Centre for Cancer Research, known by its acronym N2CR, aims to develop innovative new ways to detect, cure and prevent cancer through undertaking internationally leading fundamental research that advances the understanding of cancer.

Cardiovascular-Metabolic disease (CVD) is widely recognised as the top disease burden locally and internationally, accounting for approximately 30% of local deaths in 2015.

Digital Medicine and AI will create vitally needed solutions that can be rapidly deployed due to the core expertise possessed by WisDM.

The healthy longevity programme aims to bring together scientists and clinicians to investigate the multifaceted aspects of ageing in an effort to provide a more comprehensive understanding of the biology of ageing.

Maximising human potential for health and productivity. We are a inter-disciplinary group of researcher from the basic science and clinical departments at NUS.

The Infectious Diseases programme aims to provide a holistic, patient-centric approach to infectious diseases that are relevant to Singapore and the Region.

The Immunology Programme aims to understand the role of the immune system in health and diseases and its regulation with the goal of enabling discovery and development of more effective immunotherapy.

Nanomedicine TRP focuses on the development of nanomedical technologies based on nanoparticles designed for advanced diagnostics and targeted delivery.

Precision medicine is defined as an approach that combines molecular data at systems scale level (e.g. omics of genes, proteins, lipids, sugars, etc.) and environmental, lifestyle and healthcare data to optimise health and improve disease management of the population

The Synthetic Biology for Clinical & Technological Innovation (SynCTI) translates basic research excellence with clinical medicine to impact positive health outcomes for Singapore.